What does the evidence say about erythromycin exposure during the first trimester of pregnancy and congenital malformations?

Evidence on first-trimester erythromycin exposure is conflicting: most observational studies, covering over 24,000 exposures, suggest no association with major congenital malformations, but limited epidemiological evidence suggests a small increased risk, specifically of cardiovascular malformations.